Browse by ▼

Becton Dickinson

  • Does the Healthcare Industry mean Stability?

    By tarun bachhawat - May 14, 2013 | Tickers: BDX, COV, NVO

    A leading medical technology company, Becton, Dickinson and Company's (NYSE: BDX) earnings were better than expected. It is one of the few medical companies that is able to deliver organic growth in a challenged healthcare industry. 

    A decent quarter
     
    Becton Dickinson reported revenue of $2 billion for the quarter and profit of $275.6 million, beating Wall Street's estimate by $0.04 per share. Revenue from sales in more »

  • The Best In An Expensive Sector

    By Matthew Frankel - May 13, 2013 | Tickers: BAX, BDX, MDT

    Medtronic Inc. (NYSE: MDT) is one of the leading manufacturers of equipment for the health care industry.  In fact, the company has a leading market share in several categories, including pacemakers, defibrillators, and diabetes products just to name a few.  The company has grown its revenues tremendously over the past decade (see below), with sales up each and every year, including the entire tumultuous 2008-2010 period.  How many other health more »

  • This Large Cap Manufacturer Is a Steal Below Liquidation Value

    By Ted Cooper - May 7, 2013 | Tickers: BDX, GLW, TEL

    It is not often that you come across a large cap stock trading below liquidation value, but that is exactly the case with Corning (NYSE: GLW). The company sells right at, or slightly below, tangible book value, which is a rough approximation of what shareholders would receive if the company decided to close its doors and sell its assets today.

    Although Corning is unlikely to liquidate in the near future more »

  • This Medical Company Is Not Cheap

    By Anh HOANG - May 2, 2013 | Tickers: BDX, BCR, COV

    Recently, Covidien (NYSE: COV) witnessed a significant decline of nearly 7% after it announced sluggish second-quarter earnings. Even after the drop, Covidien’s share price has gained more than 7.3% since the beginning of the year. The company is currently in the portfolios of several famous investors including Ray Dalio, Steven Cohen, and Paul Tudor Jones. Should we consider a recent drop in its share price as an investment more »

  • Dividend Aristocrats That Sweep You Off Your Feet

    By AnnaLisa Kraft - May 1, 2013 | Tickers: ADM, BDX, DOV, CB, WAG

    In an effort to educate the 34% of women who know nothing of investing, Yahoo! Finance has a saucy video for the ladies featuring three barechested studs representing stocks, bonds, and mutual funds. Why Mr. Stocks is the skinniest, I'm sure I don't know, because how much more appealing would Mr. Stocks be if they mentioned how he bulks up when you add dividends?

    Maybe they should have more »

  • A Look at Fundamentals Ahead of Upcoming Earnings

    By John Macris - May 1, 2013 | Tickers: AIG, BDX, K

    First quarter earnings season is well underway, and a clear trend has yet to emerge among the various reports so far. Companies that have a majority exposure to the United States have fared well, while multinationals with European exposure have provided a lukewarm outlook.

    Market participants also received significant economic data within the last week. Gross domestic product rose at a 2.5% pace during Q1, driven in large part more »

  • Trounce the Market With This Diabetes Care Company

    By Greg Williamson - April 28, 2013 | Tickers: BDX, LLY, NVO, SNY

    Diabetes currently affects an estimated 350 million people worldwide. This number is projected to grow to well over 500 million people by 2030.

    Diabetes is a very serious disease that results from high levels of glucose caused by the body not being able to effectively produce insulin (type 1 diabetes) or use insulin (type 2 diabetes). Diabetes is a leading cause of a wide variety of complications including kidney failure more »

  • Buy This Healthcare Outperformer

    By Piyush Arora - April 19, 2013 | Tickers: BAX, BDX, BCR

    The healthcare industry is known to have a stable topline and usually attracts income growth investors. But over the last year, shares of Baxter International (NYSE: BAX) and Becton, Dickinson & Co. (NYSE: BDX) have risen by nearly 25% and 26%, respectively. These companies have not only outperformed their peers, but also carry a solid yield. But despite the recent rally, I think the healthcare industry is still ripe for value more »

  • 1 Pharma Stock to Buy, 1 to Sell

    By Masam Abbas - April 16, 2013 | Tickers: ABBV, BDX, JNJ

    The earnings season for pharmaceutical stocks will be kicked off by Johnson & Johnson (NYSE: JNJ) on April 16. Let’s have a look at the earnings preview of two important stocks in this space to see what this industry holds for the market:

    AbbVie Inc. (NYSE: ABBV)

    AbbVie is expected to announce its quarterly results on April 26. The company is expected to post an EPS of $0.66 and more »

  • 1 Pharma Stock to Buy, 1 to Sell

    By Masam Abbas - April 16, 2013 | Tickers: ABBV, BDX, JNJ

    The earnings season for pharmaceutical stocks will be kicked off by Johnson & Johnson (NYSE: JNJ) on April 16. Let’s have a look at the earnings preview of two important stocks in this space to see what this industry holds for the market:

    AbbVie Inc. (NYSE: ABBV)

    AbbVie is expected to announce its quarterly results on April 26. The company is expected to post an EPS of $0.66 and more »

  • 1 Pharma Stock to Buy, 1 to Sell

    By Masam Abbas - April 14, 2013 | Tickers: ABBV, BDX, JNJ

    The earnings season for Pharma stocks is expected to be kicked off by Johnson & Johnson on April 16. Let’s have a look at the earnings preview of two important stocks in this space to see what this industry holds for the market:

    AbbVie Inc. (NYSE: ABBV)

    The forecast for 1QQ13

    The company is expected to announce its quarterly results on April 26. The company is expected to post an more »

  • Are These 2 Medical Device Stocks Cheap For A Reason?

    By Joseph Harry - April 12, 2013 | Tickers: BDX, JNJ, MDT

    With the market currently flirting with new highs, and every dip seemingly being bought up, I am continually searching for bargains. Energy and some "big tech" names look somewhat attractive, valuation-wise at least, but I've already got enough of those kinds of stocks.

    Then I found a couple of medical-device makers that appear to be trading at a discount to the overall market. With the Dow sporting a P more »

  • Are These 2 Medical Device Stocks Cheap For A Reason?

    By Joseph Harry - April 9, 2013 | Tickers: BDX, JNJ, MDT

    With the market currently flirting with new highs, and every dip seemingly being bought up, I am continually searching for bargains. Energy and some "big tech" names look somewhat attractive, valuation wise at least, but I've already got enough of those kind of stocks. Then I found a couple of medical device makers, who appear to be trading at a discount to the overall market. With the Dow sporting more »

  • Buy This Healthcare Outperformer

    By Piyush Arora - April 6, 2013 | Tickers: BAX, BDX, BCR

    The healthcare industry is known to have a stable topline and usually attracts income growth investors. But over the last year, shares of Baxter International (NYSE: BAX) and Becton, Dickinson & Co. (NYSE: BDX) have risen by nearly 25% and 26%, respectively. These companies have not only outperformed their peers, but also carry a solid yield. But despite the recent rally, I think the healthcare industry is still ripe for value more »

  • Buy This Healthcare Outperformer

    By Piyush Arora - April 6, 2013 | Tickers: BAX, BDX, BCR

    The healthcare industry is known to have a stable topline and usually attracts income growth investors. But over the last year, shares of Baxter International (NYSE: BAX) and Becton, Dickinson & Co. (NYSE: BDX) have risen by nearly 25% and 26%, respectively. These companies have not only outperformed their peers, but also carry a solid yield. But despite the recent rally, I think the healthcare industry is still ripe for value more »

  • An Outperformer in Healthcare

    By Piyush Arora - April 3, 2013 | Tickers: BAX, BDX, BCR

    Healthcare industry is known to have a stable topline and steady rewards and usually attracts income growth investors. But over the last year, shares of Baxter International (NYSE: BAX) and Becton, Dickinson & Co. (NYSE: BDX) have risen by nearly 25% and 26% respectively. These companies have not only outperformed their peers, but also carry a solid yield. But despite the recent rally, I think Healthcare industry is still ripe for more »

  • Three Outside the Box Biotechs

    By Streetwise Reports - April 1, 2013 | Tickers: BDX, LGND, MNKD, ONXX, UNIS

    By George S. Mack of The Life Sciences Report

    I had a really nice chat with Griffin Securities analyst and scientific director Keith Markey about a wide-ranging group of topics. My goal is to always talk about individual biotech and sometimes medtech stocks, but we got started on another subject right away. Although he’s been an analyst for 25 years now, Markey started his career as a molecular biologist more »

  • Billionaire Michael Price’s Cheap Stock Picks

    By Meena Krishnamsetty - March 15, 2013 | Tickers: BDX, COP, INTC, KALU

    In mid February, hedge funds and other major investors filed their 13Fs with the SEC; these filings disclosed many of their long equity positions as of the end of December. Even though there is a lag in this information, there are still multiple ways for investors to use it. For example, the most popular small cap stocks among hedge funds produce an average excess return of 18 percentage points per more »

  • A Value Play in Healthcare

    By Piyush Arora - February 23, 2013 | Tickers: BAX, BDX, BCR

    According to various sources, around 78.3 million babies were born in the US, between 1946 and 1964 i.e. post World War 2. People of this generation are often referred as baby boomers, the era is remembered as the baby boom. Today, those babies have grown up and are aged between 49 and 67 years. It’s a well-known fact that the elderly have greater health concerns, and those more »

  • This Company’s Gorilla Glass Can Make You Bank Next Year

    By Meena Krishnamsetty - December 31, 2012 | Tickers: MMM, BDX, GLW, PPG, TEL

    Editor's Note: TEL sold their Touch Screen business in May 2012. This version has been corrected and we regret the error.

    Corning (NYSE: GLW) is expected to post sales growth of 6% in 2013 on the back of LCD improvements following weakness in 2012. Macro concerns have pressured the company of late, which has been essentially flat year-to-date. Billionaire Ray Dalio upped his stake over 150% in Corning last more »

  • Page 1 of 2